XBP1 and colorectal cancer: The inhibitor proved to be effective against ER stress-induced XBP1 mRNA splicing in human colorectal cancer HCT116 cells, and it was shown to inhibit the cleavage of XBP1 mRNA by purified IRE1-C in vitro as effectively as 4μ8C, in a dose-dependent manner.